Login / Signup

Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.

Eric A DeckersSchelto KruijffEsther BastiaannetRobert J van GinkelJosette E H M Hoekstra-WeebersHarald J Hoekstra
Published in: Journal of surgical oncology (2021)
Obesity was not associated with DFI, MSS, or OS in patients with clinical stage IB-II melanoma who underwent SLNB.
Keyphrases
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • type diabetes
  • skin cancer
  • weight gain
  • high fat diet induced
  • free survival